SKLB 1028

• Description:

  SKLB 1028 (Ruserontinib) is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. SKLB 1028 shows excellent activity in FLT3-driven AML models and considerable potency in CML models containing Abl mutants.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  443.55

• Molecular Formula:

  C24H29N9

• Notes:

  Research use only, not for human use.

• Receptor:

  EGFR | FLT | Bcr-Abl

• CAS Number:

  1350544-93-2